Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

被引：0
|
作者：
J. De Castro
J. L. González-Larriba
S. Vázquez
B. Massutí
J. M. Sanchez-Torres
M. Dómine
P. Garrido
A. Calles
A. Artal
R. Collado
R. García
M. Sereno
M. Majem
J. A. Macías
O. Juan
J. Gómez-Codina
B. Hernández
M. Lázaro
A. L. Ortega
M. Cobo
J. M. Trigo
E. Carcereny
C. Rolfo
S. Macia
J. Muñoz
P. Diz
M. Méndez
F. Rosillo
L. Paz-Ares
J. V. Cardona
D. Isla
机构：
[1] Hospital Universitario La Paz-IDIPAZ,Medical Oncology Unit––Department of Translational Oncology
[2] Hospital Clínico Universitario San Carlos,undefined
[3] Hospital Universitario Lucus Augusti,undefined
[4] Hospital General Universitario de Alicante,undefined
[5] MD Anderson Cancer Center Madrid,undefined
[6] Fundación Jiménez Díaz,undefined
[7] Hospital Ramón y Cajal,undefined
[8] Centro Integral Oncológico Clara Campal,undefined
[9] Hospital Universitario Miguel Servet,undefined
[10] Hospital San Pedro de Alcántara,undefined
[11] Hospital Universitario Gregorio Marañón,undefined
[12] Hospital Infanta Sofía,undefined
[13] Hospital de la Santa Creu i Sant Pau,undefined
[14] Hospital General Universitario Morales Meseguer,undefined
[15] Hospital Arnau Vilanova,undefined
[16] Hospital La Fe,undefined
[17] Complejo Hospitalario de Navarra––Hospital de Navarra,undefined
[18] Complexo Hospitalario Universitario de Vigo,undefined
[19] Complejo Hospitalario de Jaén,undefined
[20] Hospital Regional Universitario Carlos Haya,undefined
[21] Hospital Universitario Virgen de la Victoria,undefined
[22] Institut Català d’Oncologia-Hospital Universitari Germans Trias i Pujol,undefined
[23] University Hospital of Antwerp,undefined
[24] Hospital General Universitario de Elda,undefined
[25] Hospital Universitario Doctor Peset,undefined
[26] Complejo Asistencial Universitario de León,undefined
[27] Hospital Universitario de Móstoles,undefined
[28] Complejo Hospitalario Torrecárdenas,undefined
[29] Hospital Universitario Virgen del Rocío,undefined
[30] Roche Farma,undefined
[31] S.A.,undefined
[32] Hospital Clínico Universitario Lozano Blesa,undefined
来源：
Clinical and Translational Oncology | 2017年 / 19卷
关键词：
Non-squamous NSCLC; First-line treatment; Bevacizumab; Bevacizumab maintenance therapy; Routine clinical practice setting; Observational study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：219 / 226
页数：7
相关论文
共 50 条
  • [21] Long-term responders to first-line bevacizumab-based therapy in metastatic breast cancer (MBC) patients: Results of the observational study LORENA.
    Vazquez, Manuel Ramos
    Redondo, Andres
    Manso, Luis
    Gil, Miguel
    Garau, Isabel
    Perez-Carrion, Ramon
    Garcia-Garre, Elisa
    Rodriguez, Cesar Augusto
    Chacon, Jose Ignacio
    Lopez-Vivanco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Clinical outcomes for special populations of patients treated with first-line bevacizumab-based therapy in an observational study (AVVA)
    De Castro, J.
    Domine, M.
    Garcia-Bueno, J.
    Saura, S.
    Garcia, R.
    Sereno, M.
    Juan Vidal, O.
    Pujol, E.
    Rubio-Viqueira, B.
    Cobo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [23] SAFETY OF BEVACIZUMAB (BV)-BASED THERAPY AS FIRST-LINE TREATMENT OF ELDERLY PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER ( NSCLC): MO19390 (SAIL)
    Reck, M.
    Mazieres, J.
    Mark, Z.
    Schuette, W.
    Dansin, E.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S83 - S83
  • [24] Clinical Efficacy and Tolerability of Bevacizumab in Elderly Patients With Advanced Non-Squamous NSCLC
    Santos, Edgardo S.
    Castillero, Lilibeth
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S200 - S200
  • [25] NETWORK META-ANALYSIS OF EFFICACY OF PEMETREXED- OR BEVACIZUMAB-BASED REGIMENS IN FIRST-LINE AND MAINTENANCE TREATMENT FOR ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
    Yang, Y. P.
    Chen, G.
    Yao, D.
    Wang, X.
    Hu, T. L.
    Chi, H. D.
    Zhang, L.
    RESPIRATORY MEDICINE, 2017, 132 : 272 - 272
  • [26] Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer
    Xu, Bei
    Liu, Peng
    Yin, Yongmei
    Liu, Ping
    Shu, Yongqian
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 763 - 769
  • [27] EFFICACY AND SAFETY OF BEVACIZUMAB-BASED THERAPY IN ADVANCED NON-SQUAMOUS NON SMALL CELL LUNG CANCER : A RETROSPECTIVE STUDY.
    Ito, Kentaro
    Hataji, Osamu
    Naito, Masahiro
    Watanabe, Fumiaki
    Takao, Motoshi
    Gabazza, Esteban C.
    Taguchi, Osamu
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1166 - S1166
  • [28] MO19390 (SAiL): first-line bevacizumab-based therapy in advanced non-small cell lung cancer (NSCLC) - outcome by chemotherapy regimen
    Laskin, Janessa
    Crino, Lucio
    Tsai, Chun-Ming
    Pavlakis, Nick
    Thatcher, Nicholas
    Dansin, Eric
    Griesinger, Frank
    Isla, Dolores
    Eberhardt, Wilfried
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S359 - S359
  • [29] Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective study
    Ni Jun
    Wang Hanping
    Si Xiaoyan
    Xu Yan
    Wang Mengzhao
    Zhang Xiaotong
    Zhang Li
    THORACIC CANCER, 2020, 11 (07) : 1869 - 1875
  • [30] Factors Associated with Long-Term Survival of Stage IV NSCLC Patients on First-Line EGFR-Targeting Therapy
    Gibson, A.
    D'Silva, A.
    Tudor, R.
    Elegbede, A.
    Otsuka, S.
    Bebb, G.
    Hao, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S979 - S980
12345